Quality assurance of pelvic autonomic nerve-preserving surgery for advanced lower rectal cancer--preliminary results of a randomized controlled trial.
BACKGROUND
Pelvic autonomic nerve-preserving (PANP) lateral node dissection (LLND) has been introduced in rectal cancer surgery in Japan, but quality assurance of this approach has not been tested by randomized controlled trials.


METHODS
Patients with advanced lower rectal cancer were randomized either to complete PANP + LLND surgery combined with intraoperative radiotherapy (preserved group; n = 28) or to pelvic autonomic nerve resection + LLND surgery (resected group; n = 27). Operation-related parameters were compared statistically.


RESULTS
Patient and tumor characteristics were well comparable. The incidence of anastomotic breakdown, intrapelvic abscess, and small bowel obstruction was not different between the two groups. In the preserved group, no patients had ureteral stenosis, pelvic bone fractures, or peripheral neuropathy due to intraoperative radiotherapy. Sphincter-preserving operation was possible with similar ratio in both groups. Adjuvant chemotherapy was given with similar ratio in both groups. The average operation time was 513 minutes in the preserved group and 409 minutes in the resected group, with a significant difference between the two groups. The average amount of hemorrhage was not different significantly between the preserved group (996 ml) and the resected group (970 ml). Circumferential resection margin status and operative curability were similar between the two groups. The average number of harvested and metastatic nodes in the mesentery and pelvic sidewall was not different significantly between the two groups.


CONCLUSIONS
This study revealed, for the first time, that the surgical quality of PANP + LLND is the same as pelvic autonomic nerve resection + LLND.
Department of Surgery and Radiation Oncology, Kyorin University, 6-20-2, Shinkawa, Mitaka City, Tokyo, 181-8611, Japan. masaki@ks.kyorin-u.ac.jp
Tadahiko
T
Masaki
Hiroyoshi
H
Matsuoka
Takaaki
T
Kobayashi
Nobutsugu
N
Abe
Makoto
M
Takayama
Ayako
A
Tonari
Masanori
M
Sugiyama
Yutaka
Y
Atomi
D000368:Aged; D000970:Antineoplastic Agents; D017776:Autonomic Pathways / Q000601:surgery*; D013505:Digestive System Surgical Procedures / Q000592:standards*; D005260:Female; D006801:Humans; D007432:Intraoperative Period; D007564:Japan; D008197:Lymph Node Excision / Q000592:standards*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D019635:Neurosurgical Procedures / Q000592:standards*; D010388:Pelvis / Q000294:innervation / Q000473:pathology; D011785:Quality Assurance, Health Care; D018714:Radiotherapy, Adjuvant; D012004:Rectal Neoplasms / Q000601:surgery*; D012007:Rectum / Q000294:innervation
D000970:Antineoplastic Agents